Medicure Inc. (TSXV:MPH)
Canada · Delayed Price · Currency is CAD 2.500
+0.600 (31.58%)
Aug 28, 2026, 3:56 PM EST
Medicure Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 26 | 12 | 9 | 15 | 10 | 9 | |
Market Cap Growth | 117.39% | 29.54% | -37.14% | 41.12% | 9.78% | -24.17% |
Enterprise Value | 25 | 9 | 5 | 10 | 7 | 7 |
Last Close Price | 2.50 | 1.14 | 0.88 | 1.40 | 1.01 | 0.92 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 7.59 | - |
Forward PE | - | 11.48 | 11.48 | 11.48 | 11.48 | 11.48 |
PS Ratio | 0.81 | 0.41 | 0.42 | 0.67 | 0.45 | 0.43 |
PB Ratio | 2.25 | 0.92 | 0.44 | 0.73 | 0.49 | 0.51 |
P/TBV Ratio | 107.37 | 13.21 | 1.14 | 1.86 | 1.44 | 2.23 |
P/FCF Ratio | - | - | 6.67 | 7.03 | 5.71 | 2.61 |
P/OCF Ratio | - | - | 6.67 | 7.03 | 5.66 | 2.36 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.78 | 0.30 | 0.24 | 0.44 | 0.30 | 0.34 |
EV/EBITDA Ratio | - | - | - | 7.29 | 2.10 | 11.33 |
EV/EBIT Ratio | - | - | - | - | 5.71 | - |
EV/FCF Ratio | - | - | 3.79 | 4.62 | 3.75 | 2.04 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.06 | 0.07 | 0.04 | 0.03 | 0.04 | 0.06 |
Debt / EBITDA Ratio | - | - | - | 0.41 | 0.26 | 1.80 |
Debt / FCF Ratio | - | - | 0.64 | 0.26 | 0.47 | 0.32 |
Net Debt / Equity Ratio | -0.10 | -0.23 | -0.30 | -0.29 | -0.19 | -0.14 |
Net Debt / EBITDA Ratio | 0.20 | 0.58 | 6.23 | -4.43 | -1.23 | -3.88 |
Net Debt / FCF Ratio | 0.59 | 5.26 | -4.59 | -2.80 | -2.21 | -0.70 |
Asset Turnover | 1.26 | 1.06 | 0.76 | 0.75 | 0.79 | 0.70 |
Inventory Turnover | 5.29 | 5.50 | 2.85 | 2.52 | 2.13 | 2.13 |
Quick Ratio | 0.61 | 0.75 | 1.49 | 1.41 | 1.25 | 0.98 |
Current Ratio | 0.97 | 1.02 | 1.89 | 1.92 | 1.77 | 1.48 |
Return on Equity (ROE) | -49.88% | -42.13% | -5.11% | -4.51% | 6.93% | -3.87% |
Return on Assets (ROA) | -17.78% | -15.76% | -5.92% | -1.84% | 2.56% | -4.99% |
Return on Invested Capital (ROIC) | -64.88% | -56.40% | -19.18% | -5.50% | 7.15% | -14.78% |
Return on Capital Employed (ROCE) | -61.30% | -51.60% | -12.90% | -4.20% | 5.50% | -12.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -28.56% | -59.65% | -11.31% | -6.31% | 13.18% | -7.71% |
FCF Yield | -7.38% | -4.71% | 14.99% | 14.23% | 17.52% | 38.30% |
Buyback Yield / Dilution | - | - | - | -1.80% | -1.80% | 4.15% |